Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Weitz Large Cap Equity Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+6.17%
YTD-0.04%
Annualized+10.05%
Positioning StanceCONSTRUCTIVE
Market CapLarge Cap
GeographyUS
Digest Analysis
Quick Take
"Constructive on quality compounders trading at attractive price-to-value discounts, initiating new aerospace aftermarket holdings in $TDG and Honeywell Aerospace while rotating capital out of $NVDA and $CSGP."
Executive Summary
The Weitz Large Cap Equity Fund Institutional Class delivered a return of 6.17% net of fees for the third quarter of 2026, significantly outperforming the Bloomberg U.S. 1000 Index return of 1.78%. Year-to-date, the Institutional Class generated a return of -0.04% net of fees compared to 12.58% for the benchmark. Fund outperformance during the quarter was driven by concentrated slugging percentage, with key winners posting quarterly returns between 28% and 49%, despite broad market headwinds where over 60% of index equities declined.
Macroeconomic conditions remained unsettled despite broad indices trading near historical highs. Portfolio managers navigated ongoing conflict in the Middle East, sustained elevations in crude oil prices, and material upward yield curve shifts. The team observed pervasive red ink across both equity and fixed income asset classes, prompting a disciplined emphasis on businesses demonstrating durable organic expansion and pricing power over broad cyclical beta.
Portfolio activity was characterized by opportunistic capital rotation and targeted redeployment. The managers initiated new stakes in TransDigm Group and Honeywell Aerospace, building a 2.9% combined basket of aerospace aftermarket exposure alongside HEICO. Additional capital was deployed to more than double Taiwan Semiconductor and increase ASML Holding and Martin Marietta Materials. To fund these additions and reshape industrial exposure, complete exits were executed in NVIDIA, CoStar Group, and Ingersoll Rand, while Bio-Techne was largely trimmed near its buyout price.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
72%
CautiousHigh
High Conviction (72%)
The portfolio maintains high concentration with 29 total holdings and the top 10 positions representing over half of total net assets. Position adjustments were explicit and targeted, such as more than doubling Taiwan Semiconductor and establishing a distinct 2.9% aerospace basket. Conviction is moderated slightly by diversified holdings below the top tier and the short leash maintained on turnarounds like Honeywell Aerospace.
Growth Outlook
58%
BearishBullish
Neutral (58%)
Management acknowledges that the broader investing backdrop is unsettled, pointing out elevated oil prices, rising interest rates, and breadth weakness where over 60% of index stocks fell. However, their outlook on their own holdings remains positive, highlighting profitable growth, decent operating momentum, and an attractive portfolio price-to-value ratio in the high-80s.
Risk Appetite
65%
DefensiveAggressive
Balanced (65%)
Positioning reflects a healthy risk posture with capital actively redeployed into new long positions like TransDigm and Honeywell Aerospace, alongside doubling existing stakes in semiconductors. However, the managers maintain discipline by booking gains in NVIDIA, trimming winner position sizes, and monitoring speculative turnarounds on a short leash.
Capital Deployment
60%
De-riskingDeploying
Net Neutral (60%)
Deployment was balanced during the quarter with new entries in TransDigm and Honeywell Aerospace, and doubled exposure in Taiwan Semiconductor, financed by complete exits in NVIDIA, CoStar Group, and Ingersoll Rand, as well as monetization of Bio-Techne.
Forward Guidance
70%
CautiousExpansionary
Expansionary (70%)
The team signals an active bias toward accumulating undervalued compounders, explicitly noting they have plenty of capacity to add to aerospace holdings if their timing proves early. Trims of recent winners and buyout targets like Bio-Techne provide dry powder for selective deployment.
Language Signal
64%
BearishBullish
Balanced (64%)
Commentary balances constructive terms like strong organic growth, reasonable value, and value creation against detached realism regarding Middle East conflicts, rising rates, and price-cost pressures. Overall phrasing remains directional toward quality compounders growing profitably.
Perceived Risk
62%
Low RiskElevated
Moderate Risk (62%)
Risks are explicitly identified across geopolitical conflicts in the Middle East, sustained elevated crude oil prices, rising interest rates across the yield curve, and price-cost inflation pressures affecting corporate margins.
Opportunity Density
62%
ScarceAbundant
Selective (62%)
The managers identify attractive opportunities selectively rather than broadly, finding idiosyncratic value in aerospace aftermarket spin-offs, limestone acquisitions, and semiconductor value chains while exiting names with disappointing outlooks.
Time Horizon
75%
Short-TermLong-Term
Decade+ (75%)
Management emphasizes a multi-year horizon, noting that their portfolio price-to-value estimate in the high-80s offers adequate multi-year return potential and that the long-term outlook for compounders like Vulcan Materials remains fully intact.